From product launches and milestones, here are five updates in orthobiologics since March 28.
1. Lenoss Medical’s OsteoPearl procedure reached its 150th case. OsteoPearl is an allograft designed to augment vertebral compression fractures.
2. Spine Wave released its Tempest demineralized cortical fibers in a full-market release.Tempest is made entirely of human allograft cortical bone with osteoconductive and osteoinductive potential.
3. Ventris Medical earned FDA clearance to use its Backpack bone graft in intervertebral disc space. Backpack is offered in two versions — one with Allocell AF allograft fibers and one with surface activated amplify granules.
4. A study reporting on DiscGenics’ cell therapy phase 1 and 2 study was selected as one of three of the best and most influential articles published in the International Journal of Spine Surgery in 2024, according to an April 9 news release.
5. CGBIO, a South Korea-based company, earned the FDA’s investigational device exemption approval for its Novosis putty for spinal fusions. The bone graft incorporates rhBMP-2 and is designed to enhance high-density bone formation and minimize ectopic bone growth.
